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Abstract
The objective of this study was to determine the seroprevalence of hepatitis B virus (HBV) and
hepatitis C virus (HCV) infections and the possible risk factors among blood donors in Nyala, South
Dar Fur State of western Sudan, which has never been studied before. A total of 400 male blood
donors were tested for the detection of HBsAg and anti-HCV antibodies, (6.25%) were found
reactive for HBsAg and (0.65%) were reactive for anti-HCV antibodies. The highest seroprevalence
(30.8%) was found in those between 19-24 and 37-42 years for HBsAg, whereas it was (50%) in
those between 31-36 years for anti-HCV antibodies. Unprotected sexual activities (20%) was the
most apparent predisposing risk factor for both HBV and HCV seroreactors, followed by razor
sharing (13.3%), parenteral drug injections (10%), history of migration to Egypt and alcoholism
(6.6%) for each, tattooing and surgical procedures (3.3%) for each and (36.6%) were not aware for
their condition. Serum alanine aminotansferase (ALT) was elevated in (30.7%) of HBV seroreactors
and in (50%) of HCV seroreactors. Serum albumin was reduced in (23.1%) HBV and in (50%) HCV
seroreactors. The study concluded that the seroprevalence of HBV and HCV was in an
intermediate and low rates respectively and unprotected sexual activities was the major risk factor
for infection in the population studied.
Introduction
Hepatitis B virus (HBV) and hepatitis C virus (HCV) are
the two major causes of chronic liver disease worldwide.
Both viruses are hepatotrophic, but not directly cytopathic
and elicit progressive liver injuries resulting in the end-
stage liver disease unless effectively eradicated [1,2]. In
Sudan, the incidence of hepatocellular carcinoma (HCC)
is high and increasing, in one study conducted in 1996-
1998 among 150 HCC patients, indicated that HBV and
HCV are important risk factors of HCC in Sudan [3]. Both
human viral infections can be transmitted by various
routes, i.e. blood and blood products (e.g. blood transfu-
sion), sexual, oral, vertical and horizontal transmission
[4-6]. The well known and routinely used screening sero-
logic techniques Enzyme Linked Immunosorbent Assay
(ELISA) and Immunochromatographic test (ICT) were
both employed to detect HBsAg and anti-HCV antibodies
among male blood donors attending Nyala Teaching Hos-
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pital. Demographic studies using interviewing question-
naire were also used to illustrate the possible risk factors
for both viral infections. The basic epidemiological data
for these viruses might be of great importance to the pro-
gramme managers and health planers, so as to initiate the
screening package in the blood banks. A little proper pub-
lished data of the epidemiology of viral hepatitis is avail-
able in Sudan in general and nothing in Dar Fur region
particularly. Thus the current study aimed to determine
the seroprevalence and the possible risk factors for HBV
and HCV among blood donors in Nyala.
Materials and methods
This study was conducted during the period from May to
July 2007, as a hospital based study in the city of Nyala,
South Dar Fur State, Sudan. The reason for selecting this
area was that no previous studies were done to investigate
the seroprevalence of both human viral infections. The
population of Nyala area is approximately 1.500.000.
Subjects were apparently healthy male blood donors (n =
400) attending Nyala Teaching Hospital and randomly
selected as study subjects and enrolled after interviewing
questionnaire include the demographic information (age,
sex and residence), history of previous blood transfusion
and other possible risk factors (e.g. unprotected sexual
activities). Five ml of blood were drawn from each subject;
sera were separated, aliquoted, labeled within two hours
of collection and stored at -70°C. Serum samples initially
tested for HBsAg and anti-HCV antibodies with immuno-
chromatographic test (ICT) from Advanced Quality, then
screened with a 3rd generation ELISA, Equi-HBsAg and
EIAgen anti-HCV antibodies from Equibar and Adalits
respectively.
Statistical Analysis
Processing and analysis of data were performed by means
of the statistical package for social sciences (SPSS-PC ver-
sion 10.0, computer software). Statistical significance was
taken as (P ≤ 0.01) for T-student and Chi-square tests.
Results
A total of 400 subjects were included in the study, with a
mean age of 33 years and an age range of 18-49 years, all
of them were males. The seroprevalence of HBV revealed
from ICT results was (6%), whereas it was increased to
(6.5%) by ELISA procedure ran on the same serum sam-
ples. The mean seroprevalenve of HBV calculated from
both tests was (6.25%). On the other hand the seropreva-
lence of HCV revealed from ICT results was (0.3%),
whereas it was increased to (1%) by ELISA procedure ran
on the same samples. The mean seroprevalence of HCV
calculated from both tests was (0.65%). Some selected
liver function tests e.g. serum alanine aminotransferase
(ALT) and serum albumin were done to HBV and HCV
reacted samples, ALT was elevated in (30.7%) of HBV
reacted samples while it was elevated in (50%) of HCV
reacted samples. Serum albumin was reduced in (23.1%)
of HBV reacted samples while it was also reduced in
(50%) of HCV reacted samples. The highest percentage
(30.8%) of HBV reacted samples were aged within the age
group 19-24 and 37-42 for each. On the other hand the
highest percentage (50%) of HCV reacted samples were
aged within the age group 31-36. Most (58%) of HBV
seroreactors were from Nyala city, while only (15%) were
from Kalma camp and (27%) from other South Dar Fur
State localities. In contrast (50%) of HCV seroreactors
were from Nyala and (25%) from Kalma camp and Beliel
locality for each. Unprotected sexual activities (20%) was
the apparent predisposing risk factor, followed by razor
sharing (13.3%), parenteral drug injections (10%), his-
tory of migration to Egypt and alcoholism (6.6%) for
each, tattooing and surgical procedures (3.3%) for each
and (36.6%) were not aware for their condition (figure 1).
Discussion
All subjects examined in this study were males, because
usually females do not donate blood in Sudan. This is
because socially and culturally women are not favored to
donate blood either to men or women. Usually men of
young or middle age are those who can willingly donate
their blood.
Results showed that the seroprevalence of HBV and HCV
among blood donors in Nyala was (6.25%) and (0.65%)
respectively, this indicates an intermediate HBV seroprev-
alence [7] and low level of HCV seroprevalence. The study
showed that the seroprevalene of HBV is in compliance
rate if compared to previous studies conducted in north-
ern and central Sudan (5.1%) and (5.6%) respectively
[8,9]. Whereas it was low if compared to southern Sudan
(26%)[10]. On the other hand the seroprevalence of HCV
among blood donors in Nyala is nearly the same (0.65) as
in central Sudan (0.6%)[9], whereas it was a bit lower in
comparison to northern Sudan (1.3%), Gezira state
(2.2%) and southern Sudan (3%) respectively [8,10,11].
Results showed that the ICT used in this study for HBsAg
and anti-HCV antibodies screening was less sensitive
when compared with ELISA since additional positive sam-
ples were detected by ELISA for both viruses (two for HBV
and three for HCV), this could be due to short incubation
period of the ICT employed in the study. Characteristi-
cally short incubation tests do not detect low affinity or
low concentration of antibodies as well the classic type of
immunoassays which employ longer incubation times
allowing reaction to proceed to completion. It should be
noted that the ICT may identify HBsAg and anti-HCV anti-
bodies, negative samples reasonably well, but, because of
their short incubation times the assays do not always
identify low affinity/low concentration of antibodies.Virology Journal 2009, 6:146 http://www.virologyj.com/content/6/1/146
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Therefore the potential for false negative results in short
incubation test are higher than that in Enzyme Immuno
Assay (EIAs) using longer incubation periods and multi-
ple antigens. All over it is clear that antibody to hepatitis
B surface antigen (anti HBs) could not be detected at early
stage of HBV infection i.e. before three to six weeks post
infection and also at late stage three to six months post
infection. This could explain why ICT has not detected
such samples since it is directed to anti HBs antigen. The
same reason could be also attributed to the failure of ICT
to detect HCV positive samples. These results obviously
showed that the possibility of false negative results could
be obtained by ICT which is usually practiced in Nyala
Teaching Hospital blood bank as a preliminary screening
test and thereby the risk of transfusing infected blood and
establishment of new foci of infection exist.
In this study liver damage assessment of the positive sam-
ples was performed by the alanine aminotransferase
(ALT) and albumin parameters. The ALT is thought to be
more specific indicative parameter of hepatocellular dam-
age and its results interpretation reflect the infection sta-
tus. The ALT is markedly elevated in acute infections,
mildly elevated in chronic infections and it is normal in
resolved infections [12]. Therefore results showed that
eleven of the thirty HBV and HCV positive samples has
elevated ALT, seven of them were markedly elevated (ALT
≥ 40 U/I) above the reference value (5-25 U/I) which indi-
cate an acute infection, four were have mild ALT elevation
(ALT = 28 to31 U/I) which indicate a chronic infection,
whereas the remainder nineteen positive samples with
normal ALT level which indicate a resolved infection.
The study showed that serum albumin was reduced below
the reference value (3.8-5.1 g/dl) in each of four different
HBV and HCV positive samples out of thirty (serum albu-
min ≤ 3.0 g/dl). In acute liver disease however, there may
be little or no reduction in plasma albumin as the biolog-
ical half-life of albumin is about 20 days and the frac-
tional clearance is therefore low [13]. In contrast in
chronic liver disease when large numbers of parenchymal
liver cells have been destroyed, synthesis of albumin is
impaired. In the absence of other known causes of hypo-
proteinaemia a plasma albumin concentration below 3.0
g/dl indicates liver damage [14]. More over lower serum
albumin and progressive liver disease was also associated
with the coexistence of mutant variant of viruses that
might have higher pathogenecity and replication ability
[15].
In this study the predisposing risk factors of HBV and
HCV infections were assessed using the history of the pos-
itive blood donors. Unprotected sexual activities was the
most apparent predisposing risk factor (20%), followed
by razor sharing (13.3%), parenteral drug injections
(10%), migration to Egypt and alcoholism (6.6%) for
each, tattooing and surgical procedures (3.3%) for each.
These results were in accordance with central Sudan (3%)
and Gezira state (2.7%) concerning tattooing [9,11]
whereas it was much lower than the southern Sudan for
HBV (95%) and (43%) for HCV [10]. For parenteral drug
injections these results were a bit lower than the Gezira
state (18.8%) [11] and much lower for HBV (26.7%) and
the same (10.2%) for HCV when compared to Omdur-
man area [16]. Alcoholism behavior is known to favors
viral hepatitis, such behavior reported in this study was in
compliance (8%) if compared to North Kordofan state
and Gezira state [3]. History of migration to Egypt could
be explained as a predisposing risk factor by the fact that,
previous studies has shown that the Nile delta of Egypt
has one of the highest seroprevalence rates of viral hepati-
tis infection in the world approaching (20%) [17]. Surgi-
cal procedures as a predisposing risk factor in this study
was in the same rate when compared to Gezira state
(5.1%)[11].
Unprotected sexual activities which was appeared as the
most predisposing risk factor (20%) in this study, when
compared to previous studies conducted in Sudan, no
data was available and this may be due to fact that in
Sudan, answering questions relating to sexual activity is
confidential or taboo. It should be noted that other
unknown or unstudied risk factors like circumcision, pub-
lic nail clipping and any other cultural behavior that
include direct blood contact might contribute the trans-
mission of these viruses.
Conclusion
The study concluded that the seroprevalence of HBV
(6.25%) and HCV (0.65%) was in an intermediate and
low rates respectively and unprotected sexual activities
Age groups of the HBV and HCV seroreactors (vertical axis  shows the frequency whereas the horizontal axis shows the  age group per year) Figure 1
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(20%) was the major risk factor for infection in the popu-
lation studied.
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